|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
134,770,000 |
Market
Cap: |
19.20(B) |
Last
Volume: |
995,877 |
Avg
Vol: |
1,174,722 |
52
Week Range: |
$120.62 - $144.92 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 724 |
Guru Rank Value : 1.3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Quest Diagnostics provides diagnostic information services. Co. is made up of two businesses: Diagnostic Information Services, which develops and delivers diagnostic information services, providing insights that allow and enable a range of customers, including patients, clinicians, hospitals, independent delivery networks (including hospital health systems), health plans, employers, accountable care organizations and direct contract entities; and Diagnostic Solutions, which includes Co.'s risk assessment services business, which provides solutions for insurers, and Co.'s healthcare information technology businesses, which provides solutions for healthcare providers.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
18,097 |
18,097 |
18,097 |
536,229 |
Total Sell Value |
$2,309,019 |
$2,309,019 |
$2,309,019 |
$75,325,755 |
Total People Sold |
4 |
4 |
4 |
7 |
Total Sell Transactions |
7 |
7 |
7 |
25 |
End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Mendez Manuel O. |
SVP & Chief Commercial Officer |
|
2021-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
4,926 |
29,045 |
|
- |
|
Eglinton Manner Carrie |
SVP, Advanced Diagnostics |
|
2021-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
4,926 |
24,841 |
|
- |
|
Doherty Catherine T. |
SVP, Group Exec. Clin. Fran. |
|
2021-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
3,941 |
72,352 |
|
- |
|
Rusckowski Stephen H |
Chairman, CEO and President |
|
2021-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
21,551 |
259,298 |
|
- |
|
Davis J. E. |
EVP, General Diagnostics |
|
2021-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
5,665 |
43,751 |
|
- |
|
Guinan Mark |
Executive Vice President & CFO |
|
2021-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
5,665 |
79,244 |
|
- |
|
Deppe Michael J |
VP, Corp. Controller & CAO |
|
2021-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
715 |
25,863 |
|
- |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2021-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
3,202 |
43,289 |
|
- |
|
Eglinton Manner Carrie |
SVP, Advanced Diagnostics |
|
2021-01-04 |
4 |
D |
$119.00 |
$314,160 |
D/D |
(2,640) |
19,896 |
|
- |
|
Guinan Mark |
Executive Vice President & CFO |
|
2020-12-24 |
4 |
AS |
$120.06 |
$9,840,673 |
D/D |
(81,756) |
73,579 |
|
15% |
|
Guinan Mark |
Executive Vice President & CFO |
|
2020-12-24 |
4 |
OE |
$66.51 |
$5,437,592 |
D/D |
81,756 |
155,335 |
|
- |
|
Wilensky Gail R |
Director |
|
2020-11-24 |
4 |
S |
$126.02 |
$770,120 |
D/D |
(6,111) |
16,482 |
|
-1% |
|
Wilensky Gail R |
Director |
|
2020-11-24 |
4 |
OE |
$57.67 |
$352,391 |
D/D |
6,111 |
22,593 |
|
- |
|
Stanzione Daniel |
Director |
|
2020-11-23 |
4 |
AS |
$125.73 |
$1,417,459 |
D/D |
(11,223) |
28,349 |
|
2% |
|
Deppe Michael J |
VP, Corp. Controller & CAO |
|
2020-10-21 |
4 |
AS |
$125.00 |
$1,306,250 |
D/D |
(10,450) |
25,090 |
|
-5% |
|
Deppe Michael J |
VP, Corp. Controller & CAO |
|
2020-10-21 |
4 |
OE |
$56.82 |
$598,244 |
D/D |
10,450 |
35,485 |
|
- |
|
Rusckowski Stephen H |
Chairman, CEO and President |
|
2020-10-16 |
4 |
AS |
$120.00 |
$35,039,640 |
D/D |
(291,997) |
237,747 |
|
-4% |
|
Rusckowski Stephen H |
Chairman, CEO and President |
|
2020-10-16 |
4 |
OE |
$66.51 |
$19,420,720 |
D/D |
291,997 |
529,744 |
|
- |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2020-10-14 |
4 |
AS |
$119.00 |
$4,235,329 |
D/D |
(35,591) |
40,087 |
|
-2% |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2020-10-14 |
4 |
OE |
$52.17 |
$1,856,605 |
D/D |
35,591 |
75,678 |
|
- |
|
Mendez Manuel O. |
SVP & Chief Commercial Officer |
|
2020-10-06 |
4 |
D |
$114.01 |
$669,353 |
D/D |
(5,871) |
23,982 |
|
- |
|
Doherty Catherine T. |
SVP, Group Exec. Clin. Fran. |
|
2020-09-02 |
4 |
AS |
$110.57 |
$6,458,343 |
D/D |
(58,392) |
68,411 |
|
13% |
|
Doherty Catherine T. |
SVP, Group Exec. Clin. Fran. |
|
2020-09-02 |
4 |
OE |
$66.51 |
$3,883,652 |
D/D |
58,392 |
126,803 |
|
- |
|
Ring Timothy M |
Director |
|
2020-06-08 |
4 |
AS |
$116.60 |
$1,367,718 |
D/D |
(11,730) |
20,505 |
|
3% |
|
Ring Timothy M |
Director |
|
2020-06-08 |
4 |
OE |
$57.57 |
$686,209 |
D/D |
11,730 |
32,235 |
|
- |
|
787 Records found
|
|
Page 11 of 32 |
|
|